Presenting Author University of Veterinary Medicine Hannover
Infection of mammalian cells by SARS-CoV-2 coronavirus requires primary interaction between the receptor binding domain (RBD) of viral Spike protein and the host cell surface receptor angiotensin converting enzyme 2 (ACE2) glycoprotein. Several mutations in the RBD of SARS-CoV-2 spike protein have been reported for several variants and resulted in wide spread of the COVID pandemic. For instance, the double mutations L452R and E484Q present in the Indian B.1.617 variant have been suggested to cause evasion of host immune response. The common RBD mutations N501Y and E484K were found to enhance the interaction with ACE2 receptor. In the current study, we analyzed the biosynthesis and secretion of the RBD double mutant L452R and E484Q in comparison to the wild-type RBD and the individual mutations N501 and E484K in mammalian cells. Moreover, we evaluated the interaction of those variants with ACE2 by means of expression of the S protein and co-immunoprecipitation with ACE2. Our results revealed that the double RBD mutations L452R and E484Q resulted in a higher expression level and secretion of Spike S1 protein as compared with other mutations. In addition, an increased interaction of these mutant forms with ACE2 in Calu3 cells was observed. Altogether, our findings highlight the impact of continuous S1 mutations on the pathogenicity of SARS-CoV-2 and provides further biochemical evidence for the dominance and high transmissibility of the double indian mutations
Support or Funding Information
This work has been supported by a grant NA331/15-1 from the German Research Foundation (DFG, Bonn) to HYN
